Ichor (NASDAQ:ICHR – Get Free Report) posted its quarterly earnings data on Monday. The technology company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.18, FiscalAI reports. Ichor had a positive return on equity of 0.47% and a negative net margin of 3.97%. The company had revenue of $328.70 million during the quarter, compared to analysts’ expectations of $330.15 million.
Ichor Stock Down 5.3%
ICHR stock traded down $2.06 during trading hours on Monday, hitting $36.84. The company’s stock had a trading volume of 1,387,661 shares, compared to its average volume of 981,326. The company has a quick ratio of 2.07, a current ratio of 3.70 and a debt-to-equity ratio of 0.13. Ichor has a 12 month low of $14.06 and a 12 month high of $113.58. The stock has a 50 day moving average price of $53.07 and a two-hundred day moving average price of $60.47. The company has a market capitalization of $1.38 billion, a PE ratio of -31.49 and a beta of 1.79.
Insider Buying and Selling
In other Ichor news, Director Iain MacKenzie sold 20,000 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $50.66, for a total transaction of $1,013,200.00. Following the completion of the transaction, the director owned 102,427 shares of the company’s stock, valued at $5,188,951.82. The trade was a 16.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Bruce Ragsdale sold 10,587 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $51.93, for a total transaction of $549,782.91. Following the completion of the transaction, the chief operating officer owned 92,324 shares of the company’s stock, valued at approximately $4,794,385.32. This represents a 10.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 46,740 shares of company stock worth $2,602,960. 1.70% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the company. B. Riley Financial decreased their price target on Ichor from $125.00 to $105.00 and set a “buy” rating for the company in a research note on Tuesday, August 4th. TD Cowen cut their price objective on Ichor from $115.00 to $100.00 and set a “buy” rating for the company in a research report on Tuesday, August 4th. Zacks Research lowered shares of Ichor from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ichor in a research note on Monday, September 21st. Finally, UBS Group set a $82.00 target price on shares of Ichor in a research note on Thursday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.89.
View Our Latest Stock Report on Ichor
Ichor Company Profile
Ichor Holdings, Ltd. (NASDAQ: ICHR) is a supplier to the semiconductor equipment industry. The company designs, engineers and manufactures critical fluid-delivery subsystems used in semiconductor fabrication equipment, including systems that deliver and control gases and chemicals during the wafer-manufacturing process.
Ichor’s products and services include gas and chemical delivery systems, precision-machined components, weldments, fluid-management assemblies and related engineering and manufacturing services.
Read More
- Five stocks we like better than Ichor
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Ichor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ichor and related companies with MarketBeat.com's FREE daily email newsletter.
